The pan-RAF-MEK non degrading molecular glue NST-628 is a potent and brain penetrant inhibitor of the RAS-MAPK pathway with activity across diverse RAS- and RAF-driven cancers

Overview of attention for article published in Cancer Discovery, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 4,250)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 39 news stories from 39 outlets.

Concurrent publication in the journal Cancer Discovery highlights NST-628's differentiated mechanism and preclinical activity…

Concurrent publication in the journal Cancer Discovery highlights NST-628's differentiated mechanism and preclinical activity…

Concurrent publication in the journal Cancer Discovery highlights NST-628's differentiated mechanism and preclinical activity…

Concurrent publication in the journal Cancer Discovery highlights NST-628's differentiated mechanism and preclinical activity…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 35 additional news stories.